Real-world evidence requires use of new tools and methods to support efficient evidence generation. Among those tools are pragmatic trials, utilization of central/single institutional review board and electronic consent, and data linkages between diverse types of data sources (eg, a trial or registry to administrative claims or electronic medical record data). This article reviews these topics in the context of describing several exemplar use cases specific to rheumatology and provides perspective regarding both the promise and potential pitfalls in using these tools and approaches.
Keywords: Data linkage; Informed consent; Osteoporosis; Pragmatic trials; Real-world evidence; Rheumatoid arthritis.
Copyright © 2019 Elsevier Inc. All rights reserved.